Down -65.65 percent in 4 Weeks, Heres Why You Should You Buy the Dip in Theseus Pharmaceuticals, Inc.
| THRXDelisted Stock | USD 3.71 0.14 3.92% |
Slightly above 55% of Theseus Pharmaceuticals' investors are presently thinking to get in. The analysis of current outlook of investing in Theseus Pharmaceuticals suggests that some traders are interested regarding Theseus Pharmaceuticals' prospects. Theseus Pharmaceuticals' investing sentiment can be driven by a variety of factors including economic data, Theseus Pharmaceuticals' earnings reports, geopolitical events, and overall market trends.
Theseus |
The heavy selling pressure might have exhausted for Theseus Pharmaceuticals, Inc. as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Read at zacks.com
 |
Theseus Pharmaceuticals Fundamental Analysis
We analyze Theseus Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Theseus Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Theseus Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Earnings Per Share
Earnings Per Share Comparative Analysis
Theseus Pharmaceuticals is currently under evaluation in earnings per share category among its peers. Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Theseus Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Theseus Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Theseus Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Theseus Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Theseus Pharmaceuticals Related Equities
| TERN | Terns Pharmaceuticals | 3.41 | ||||
| RCUS | Arcus Biosciences | 3.14 | ||||
| MRSN | Mersana Therapeutics | 3.04 | ||||
| IMRX | Immuneering Corp | 0.95 | ||||
| BPMC | Blueprint Medicines | 1.12 | ||||
| HOOK | Hookipa Pharma | 1.16 | ||||
| DAWN | Day One | 1.81 | ||||
| CGEM | Cullinan Oncology | 2.81 | ||||
| ELVN | Enliven Therapeutics | 3.36 | ||||
| GLUE | Monte Rosa | 3.52 | ||||
| DSGN | Design Therapeutics | 4.62 | ||||
| PMVP | Pmv Pharmaceuticals | 4.73 | ||||
| ERAS | Erasca | 4.95 | ||||
| XFOR | X4 Pharmaceuticals | 5.13 | ||||
| RLAY | Relay Therapeutics | 6.00 | ||||
| IPSC | Century Therapeutics | 7.74 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Consideration for investing in Theseus Stock
If you are still planning to invest in Theseus Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Theseus Pharmaceuticals' history and understand the potential risks before investing.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| CEOs Directory Screen CEOs from public companies around the world | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |